Parexel
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.
- Organization
- In this atlas
Overview
Technical summary
Sponsor class industry. No ROR record matches the name exactly.
Trials at a glance
These figures count only the registry trials in this atlas that name Parexel as a sponsor: 6 trials, 0 as lead sponsor and 6 as collaborator.
Phase and status
| Phase | Active, not recruiting | Completed | Terminated | All statuses |
|---|---|---|---|---|
| Phase 1/2 | 1 | 0 | 0 | 1 |
| Phase 2 | 0 | 3 | 1 | 4 |
| Phase 3 | 0 | 0 | 1 | 1 |
| All phases | 1 | 3 | 2 | 6 |
Start year
| Start year | Trials |
|---|---|
| 2025 | 1 |
| 2024 | 1 |
| 2023 | 1 |
| 2022 | 1 |
| 2020 | 1 |
| 2013 | 1 |
Main conditions
Main countries
- United States
- Germany
- Japan
- Poland
- Argentina
Roles
- Company
- Sponsor
Sector
Industry
The registry's words
Labels as the registry gives them, not rewritten.
- Sponsor name
- Parexel
- Sponsor class
- INDUSTRY
Record details
- Record id
cardio:org-parexel- Content hash
939174f086bd6624f3c373f77aebe27f92350bbbdaf4c18b4f6ec3d949f732ba